Trending event

Nutter presents Acceleration 2015 Early Stage Life Sciences Conference

Print PDF






Nutter is presenting Acceleration 2015, the firm’s Early Stage Life Sciences Conference on November 11. This invitation-only event connects investors, entrepreneurs, and industry executives in biotechnology, pharmaceuticals, medical devices, and health IT who are focused on growth. Key thought leaders will examine the best paths to success in an active yet volatile market. An outstanding line-up of speakers will discuss current issues and trends in early-stage development among life science companies.


Wednesday, November 11, 2015, 3:00 – 7:00 p.m.
Nutter McClennen & Fish LLP
Louis D. Brandeis Conference Center
155 Seaport Boulevard, Boston


Omar Amirana, MD
Senior Vice President I Allied Minds

Panel I: Drugs, Devices and Diagnostics: Will the IPOs, M&As and investments continue?


Ben Dunn
Managing Director
Covington Associates

Bryan Giraudo
Managing Director
Leerink Partners

Paulina Hill
Polaris Partners

James Woods
Principal - Deals, Valuation
PwC - MoneyTree™ Life Sciences Report


Luke Timmerman
Founder & Editor
Timmerman Report

Panel II: Market Viability: What are the prerequisites for success?


PJ Anand
Founder, President & CEO
Alcyone Lifesciences

Luba Greenwood
Vice President, Global M&A and Business Development
F. Hoffmann-La Roche Diagnostics

Jason Hafler
Senior Director of Investments and Principal
Sanofi-Genzyme BioVentures


Jeremy Halpern
Partner, Emerging Companies
Nutter McClennen & Fish LLP

The program will be followed by cocktails, hors d’oeuvres and networking.

To view the full agenda for this invitation-only event, or request an invitation, click here.

More Events >
Back to Page